These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 152490)
21. Considerations in immunologic monitoring of long-term transplant recipients. Thomas J; Thomas F; Johns C; Lee HM Transplant Proc; 1978 Sep; 10(3):569-72. PubMed ID: 152491 [No Abstract] [Full Text] [Related]
22. Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity. Pawelec GP; Hadam MR; Ziegler A; Lohmeyer J; Rehbein A; Kumbier I; Wernet P J Immunol; 1982 Apr; 128(4):1892-6. PubMed ID: 6460813 [No Abstract] [Full Text] [Related]
23. The induction of immunologic unresponsiveness by antigen pretreatment is mediated by a CD4 T cell that appears transiently in the spleen and subsequently in the TDL. Quigley RL; Wood KJ; Morris PJ Transplant Proc; 1989 Feb; 21(1 Pt 1):377-8. PubMed ID: 2523136 [No Abstract] [Full Text] [Related]
24. [Clinico-immunologic problems in kidney transplantation]. Lanzer G Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015 [No Abstract] [Full Text] [Related]
25. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462 [TBL] [Abstract][Full Text] [Related]
26. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT). Kedar E; Or R; Naparstek E; Zeira E; Slavin S Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477 [TBL] [Abstract][Full Text] [Related]
27. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans]. Wonigkeit K; Pichlmayr R Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112 [TBL] [Abstract][Full Text] [Related]
28. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation. Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196 [No Abstract] [Full Text] [Related]
29. Renal transplantation from HLA-haploidentical living donors. Efficacy of cyclosporine in a multicenter study. Albrechtsen D; Flatmark A; Lundgren G; Brynger H; Frödin L; Groth C; Gäbel H; Thorsby E Transplant Proc; 1987 Oct; 19(5):3579-81. PubMed ID: 2960040 [No Abstract] [Full Text] [Related]
30. Tissue typing in renal transplantation: the impact of cyclosporine. Benvenisty AI; Cohen DJ; Hardy MA Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321 [No Abstract] [Full Text] [Related]
31. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Sonoda T; Ishibashi M Clin Transpl; 1987; ():257-60. PubMed ID: 2978999 [TBL] [Abstract][Full Text] [Related]
32. In vitro generation of suppressor cells in human mixed leukocyte culture: a potential treatment modality in organ transplantation. Miller J; Clark C; Flaa C Transplant Proc; 1979 Mar; 11(1):899-903. PubMed ID: 156438 [No Abstract] [Full Text] [Related]
33. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts. Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102 [No Abstract] [Full Text] [Related]
34. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis. Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170 [TBL] [Abstract][Full Text] [Related]
35. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Barth RN; Yamamoto S; LaMattina JC; Kumagai N; Kitamura H; Vagefi PA; Awwad M; Colvin RB; Cooper DK; Sykes M; Sachs DH; Yamada K Transplantation; 2003 May; 75(10):1615-24. PubMed ID: 12777846 [TBL] [Abstract][Full Text] [Related]
36. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation. Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785 [TBL] [Abstract][Full Text] [Related]
37. Proliferative and cytotoxic capacities of human cultured T cells. Schendel DJ; Bonnard GD; Wank R; Dupont B Transplant Proc; 1978 Dec; 10(4):933-5. PubMed ID: 153619 [No Abstract] [Full Text] [Related]
38. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544 [TBL] [Abstract][Full Text] [Related]
39. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine. Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695 [TBL] [Abstract][Full Text] [Related]
40. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity. Miceli MC; Barry TS; Finn OJ Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]